Emergence and spread of predominantly communityonset Clostridium difficile PCR ribotype 244 infection in Australia, 2010 to 2012

Eurosurveillance

Volumn 20, Issue 10, 2015, Pages

  Eyre, D W ^a,b   Tracey, L ^c   Elliott, B ^d   Slimings, C ^c   Huntington, P G ^e   Stuart, R L ^f   Korman, T M ^f   Kotsiou, G ^e   McCann, R ^c   Griffiths, D ^a   Fawley, W N ^g   Armstrong, P ^c   Dingle, K E ^a   Walker, A S ^a,b   Peto, T E ^a,b   Crook, D W ^a,b   Wilcox, M H ^g   Riley, T V ^d,h  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

^c The University of Western Australia ^*  (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e ROYAL NORTH SHORE HOSPITAL   (Australia)

^f MONASH UNIVERSITY   (Australia)

^g LEEDS GENERAL INFIRMARY   (United Kingdom)

^h PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; METRONIDAZOLE; MOXIFLOXACIN; VANCOMYCIN; BACTERIAL PROTEIN; BACTERIAL TOXIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNITY CARE; DISEASE SURVEILLANCE; FEMALE; FOLLOW UP; GENE SEQUENCE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE FACILITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; PEPTOCLOSTRIDIUM DIFFICILE; PHYLOGENETIC TREE; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; RIBOTYPING; AUSTRALIA; BACTERIAL GENOME; COMMUNICABLE DISEASES, EMERGING; ENTEROCOLITIS, PSEUDOMEMBRANOUS; EPIDEMIC; GENETICS; HEALTH SURVEY; MICROBIOLOGY; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BACTERIAL PROTEINS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; GENOME, BACTERIAL; HUMANS; MALE; MIDDLE AGED; PHYLOGENY; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION SURVEILLANCE; PREVALENCE; RIBOTYPING; SEVERITY OF ILLNESS INDEX; WESTERN AUSTRALIA;

EID: 84925400272     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2015.20.10.21059     Document Type: Article

References (52)

1. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al.; Emerging Infections Program Healthcare- Associated Infections and Antimicrobial Use Prevalence Survey Team. Multistate point-prevalence survey of health care associated infections. N Engl J Med. 2014;370(13):1198-208. http://dx.doi.org/10.1056/NEJMoa1306801 PMID:24670166
2. McGlone SM, Bailey RR, Zimmer SM, Popovich MJ, Tian Y, Ufberg P, et al. The economic burden of Clostridium difficile. Clin Microbiol Infect. 2012;18(3):282-9. http://dx.doi.org/10.1111/j.1469-0691.2011.03571.x PMID:21668576
3. Jernberg C, Lofmark S, Edlund C, Jansson JK. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology. 2010;156(Pt 11):3216-23. http://dx.doi.org/10.1099/mic.0.040618-0 PMID:20705661
4. Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN. A casecontrol study of community-associated Clostridium difficile infection. J Antimicrob Chemother. 2008;62(2):388-96. http://dx.doi.org/10.1093/jac/dkn163 PMID:18434341
5. He M, Miyajima F, Roberts P, Ellison L, Pickard DJ, Martin MJ, et al. Emergence and global spread of epidemic healthcareassociated Clostridium difficile. Nat Genet. 2013;45(1):109-13. PMID:23222960
6. Riley TV, Thean S, Hool G, Golledge CL. First Australian isolation of epidemic Clostridium difficile PCR ribotype 027. Med J Aust. 2009;190(12):706-8. PMID:19527210
7. Richards M, Knox J, Elliott B, Mackin K, Lyras D, Waring LJ, et al. Severe infection with Clostridium difficile PCR ribotype 027 acquired in Melbourne, Australia. Med J Aust. 2011;194(7):369-71. PMID:21470090
8. Cheng AC, Turnidge J, Collignon P, Looke D, Barton M, Gottlieb T. Control of fluoroquinolone resistance through successful regulation, Australia. Emerg Infect Dis. 2012;18(9):1453-60. http://dx.doi.org/10.3201/eid1809.111515 PMID:22932272
9. Khanna S, Pardi DS, Aronson SL, Kammer PP, Orenstein R, St Sauver JL, et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol. 2012;107(1):89-95. http://dx.doi.org/10.1038/ajg.2011.398 PMID:22108454
10. Health Protection Agency (HPA). Quarterly Epidemiological Commentary: Mandatory MRSA bacteraemia, Clostridium difficile infection & MSSA bacteraemia (up to January – March 2012). London: HPA; 2012.
11. Viseur N, Lambert M, Delmee M, Van Broeck J, Catry B. Nosocomial and non-nosocomial Clostridium difficile infections in hospitalised patients in Belgium: compulsory surveillance data from 2008 to 2010. Euro Surveill. 2011;16(43):pii=20000. PMID:22085603
12. Slimings C, Armstrong P, Beckingham WD, Bull AL, Hall L, Kennedy KJ, et al. Increasing incidence of Clostridium difficile infection, Australia, 2011-2012. Med J Aust. 2014;200(5):272-6. http://dx.doi.org/10.5694/mja13.11153 PMID:24641152
13. Mitchell BG, Wilson F, McGregor A. An increase in community onset Clostridium difficile infection: a population-based study, Tasmania, Australia. Healthcare Infection. 2012;17(4):127-132. http://dx.doi.org/10.1071/HI12029
14. Lim SK, Stuart RL, Mackin KE, Carter GP, Kotsanas D, Francis MJ, et al. Emergence of a ribotype 244 strain of Clostridium difficile associated with severe disease and related to the epidemic ribotype 027 strain. Clin Infect Dis. 2014;58(12):1723- 30. http://dx.doi.org/10.1093/cid/ciu203 PMID:24704722
15. De Almeida MN, Heffernan H, Dervan A, Bakker S, Freeman JT, Bhally H, et al. Severe Clostridium difficile infection in New Zealand associated with an emerging strain, PCR-ribotype 244. N Z Med J. 2013;126(1380):9-14. PMID:24126745
16. Kuijper EJ, Coignard B, Tull P, ESCMID Study Group for Clostridium difficile, EU Member States, European Centre for Disease Prevention and Control. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect. 2006;12(s6) Suppl 6;2-18. http://dx.doi.org/10.1111/j.1469-0691.2006.01580.x PMID:16965399
17. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al.; Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431-55. http://dx.doi.org/10.1086/651706 PMID:20307191
18. Bauer MP, Kuijper EJ, van Dissel JT; European Society of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect. 2009;15(12):1067-79. http://dx.doi.org/10.1111/j.1469-0691.2009.03099.x PMID:19929973
19. Kato N, Ou CY, Kato H, Bartley SL, Brown VK, Dowell VR Jr, et al. Identification of toxigenic Clostridium difficile by the polymerase chain reaction. J Clin Microbiol. 1991;29(1):33-7. PMID:1993763
20. Stubbs S, Rupnik M, Gibert M, Brazier J, Duerden B, Popoff M. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett. 2000;186(2):307-12. http://dx.doi.org/10.1111/j.1574-6968.2000.tb09122.x PMID:10802189
21. Kato H, Kato N, Watanabe K, Iwai N, Nakamura H, Yamamoto T, et al. Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol. 1998;36(8):2178-82. PMID:9665986
22. Stubbs SL, Brazier JS, O'Neill GL, Duerden BI. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol. 1999;37(2):461-3. PMID:9889244
23. Knetsch CW, Lawley TD, Hensgens MP, Corver J, Wilcox MW, Kuijper EJ. Current application and future perspectives of molecular typing methods to study Clostridium difficile infections. Euro Surveill. 2013;18(4):20381. PMID:23369393
24. Clinical and Laboratory Standards Institute (CLSI). Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard – eighth edition. CLSI document M11-A8. Wayne: CLSI; 2012.
25. Lunter G, Goodson M. Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads. Genome Res. 2011;21(6):936-9. http://dx.doi.org/10.1101/gr.111120.110 PMID:20980556
26. Sebaihia M, Wren BW, Mullany P, Fairweather NF, Minton N, Stabler R, et al. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet. 2006;38(7):779-86. http://dx.doi.org/10.1038/ng1830 PMID:16804543
27. Zerbino DR, Birney E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 2008;18(5):821-9. http://dx.doi.org/10.1101/gr.074492.107 PMID:18349386
28. Didelot X, Eyre DW, Cule M, Ip CL, Ansari MA, Griffiths D, et al. Microevolutionary analysis of Clostridium difficile genomes to investigate transmission. Genome Biol. 2012;13(12):R118. http://dx.doi.org/10.1186/gb-2012-13-12-r118 PMID:23259504
29. Guindon S, Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol. 2003;52(5):696-704. http://dx.doi.org/10.1080/10635150390235520 PMID:14530136
30. Drummond AJ, Suchard MA, Xie D, Rambaut A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol. 2012;29(8):1969-73. http://dx.doi.org/10.1093/molbev/mss075 PMID:22367748
31. He M, Sebaihia M, Lawley TD, Stabler RA, Dawson LF, Martin MJ, et al. Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc Natl Acad Sci USA. 2010;107(16):7527-32. http://dx.doi.org/10.1073/pnas.0914322107 PMID:20368420
32. Valiente E, Dawson LF, Cairns MD, Stabler RA, Wren BW. Emergence of new PCR ribotypes from the hypervirulent Clostridium difficile 027 lineage. J Med Microbiol. 2012;61(Pt 1):49-56. http://dx.doi.org/10.1099/jmm.0.036194-0 PMID:21903827
33. Clements ACA, Magalhaes RJS, Tatem AJ, Paterson DL, Riley TV. Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread. Lancet Infect Dis. 2010;10(6):395- 404. http://dx.doi.org/10.1016/S1473-3099(10)70080-3 PMID:20510280
34. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, et al.; ECDIS Study Group. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011;377(9759):63-73. http://dx.doi.org/10.1016/S0140-6736(10)61266-4PMID:21084111
35. Planche TD, Davies KA, Coen PG, Finney JM, Monahan IM, Morris KA, et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentrediagnostic validation study of C. difficile infection. Lancet Infect Dis, 2013;3(11):936–945. http://dx.doi.org/10.1016/S1473-3099(13)70200-7 PMID: 24007915
36. Polgreen PM, Yang M, Bohnett LC, Cavanaugh JE. A time-series analysis of clostridium difficile and its seasonal association with influenza. Infect Control Hosp Epidemiol. 2010;31(4):382- 7. http://dx.doi.org/10.1086/651095 PMID:20175682
37. Kwong JC, Maaten S, Upshur REG, Patrick DM, Marra F. The effect of universal influenza immunization on antibiotic prescriptions: an ecological study. Clin Infect Dis. 2009;49(5):750-6. http://dx.doi.org/10.1086/605087 PMID:19624280
38. Eyre DW, Walker AS, Freeman J, Baines SD, Fawley WN, Chilton CH, et al. Short-term genome stability of serial Clostridium difficile ribotype 027 isolates in an experimental gut model and recurrent human disease. PLoS ONE. 2013;8(5):e63540. http://dx.doi.org/10.1371/journal.pone.0063540 PMID:23691061
39. Stabler RA, Gerding DN, Songer JG, Drudy D, Brazier JS, Trinh HT, et al. Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J Bacteriol. 2006;188(20):7297-305. http://dx.doi.org/10.1128/JB.00664-06 PMID:17015669
40. Hensgens MPM, Keessen EC, Squire MM, Riley TV, Koene MGJ, de Boer E, et al.; European Society of Clinical Microbiology and Infectious Diseases Study Group for Clostridium difficile (ESGCD). Clostridium difficile infection in the community: a zoonotic disease? Clin Microbiol Infect. 2012;18(7):635- 45. http://dx.doi.org/10.1111/j.1469-0691.2012.03853.x PMID:22536816
41. Squire MM, Riley TV. Clostridium difficile infection in humans and piglets: a ‘One Health’ opportunity. Curr Top Microbiol Immunol. 2013;365:299-314. http://dx.doi.org/10.1007/82_2012_237 PMID:22695920
42. Goorhuis A, Bakker D, Corver J, Debast SB, Harmanus C, Notermans DW, et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis. 2008;47(9):1162-70. http://dx.doi.org/10.1086/592257 PMID:18808358
43. Burns K, Morris-Downes M, Fawley WN, Smyth E, Wilcox MH, Fitzpatrick F. Infection due to C. difficile ribotype 078: first report of cases in the Republic of Ireland. J Hosp Infect. 2010;75(4):287-91. http://dx.doi.org/10.1016/j.jhin.2010.03.02 5 PMID:20621236
44. Rodriguez-Palacios A, Reid-Smith RJ, Staempfli HR, Daignault D, Janecko N, Avery BP, et al. Possible seasonality of Clostridium difficile in retail meat, Canada. Emerg Infect Dis. 2009;15(5):802-5. http://dx.doi.org/10.3201/eid1505.081084 PMID:19402975
45. Songer JG, Trinh HT, Killgore GE, Thompson AD, McDonald LC, Limbago BM. Clostridium difficile in retail meat products, USA, 2007. Emerg Infect Dis. 2009;15(5):819-21. http://dx.doi.org/10.3201/eid1505.081071 PMID:19402980
46. Bakri MM, Brown DJ, Butcher JP, Sutherland AD. Clostridium difficile in ready-to-eat salads, Scotland. Emerg Infect Dis. 2009;15(5):817-8. http://dx.doi.org/10.3201/eid1505.081186 PMID:19402979
47. Eckert C, Burghoffer B, Barbut F. Contamination of ready-toeat raw vegetables with Clostridium difficile in France. J Med Microbiol. 2013;62(Pt 9):1435-8. http://dx.doi.org/10.1099/jmm.0.056358-0 PMID:23449876
48. Metcalf DS, Costa MC, Dew WMV, Weese JS. Clostridium difficile in vegetables, Canada. Lett Appl Microbiol. 2010;51(5):600-2. http://dx.doi.org/10.1111/j.1472-765X.2010.02933.x PMID:21069911
49. Metcalf D, Avery BP, Janecko N, Matic N, Reid-Smith R, Weese JS. Clostridium difficile in seafood and fish. Anaerobe. 2011;17(2):85-6. http://dx.doi.org/10.1016/j.anaerobe.2011.02.008 PMID:21376822
50. Schlackow I, Walker AS, Dingle K, Griffiths D, Oakley S, Finney J, et al. Surveillance of infection severity: a registry study of laboratory diagnosed Clostridium difficile. PLoS Med. 2012;9(7):e1001279. http://dx.doi.org/10.1371/journal.pmed.1001279 PMID:22859914
51. Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, Birtles A, et al. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotypingbased surveillance scheme in England. Clin Infect Dis. 2012;55(8):1056-63. http://dx.doi.org/10.1093/cid/cis614 PMID:22784871
52. Eyre DW, Golubchik T, Gordon NC, Bowden R, Piazza P, Batty EM, et al. A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance. BMJ Open. 2012;2(3):e001124. http://dx.doi.org/10.1136/bmjopen-2012-001124